Mitozz is the best choice for mitochondrial support See why ➝

    End of Content.

    Shop Mitozz

    Peer-Reviewed Papers

    Explore published research on mitochondrial function, cellular energy, (-)-epicatechin, vascular biology, and related metabolic pathways. Browse by specialization below to quickly find the papers most relevant to your interests.

    Search Papers by Specialization

    Anticancer Effects in Triple-Negative Breast Cancer Model

    Study Title: Anticancer potential of (−)-epicatechin in a triple-negative mammary gland model

    Citation: Almaguer et al., 2021 · Journal of Pharmacy and Pharmacology

    What the Study Found: (−)-Epicatechin demonstrated anticancer activity in a triple-negative mammary gland model, reducing tumor growth and metastatic potential. It modulated pathways involved in cell proliferation, survival, and mitochondrial function. The flavanol showed promising effects without apparent toxicity to normal tissue.

    What this means in real life: Triple-negative breast cancer is particularly aggressive and often linked to high mitochondrial stress and altered energy metabolism. This study highlights (−)-epicatechin’s ability to target those pathways, slowing cancer progression at the cellular energy level. Mitochondrial support offers a complementary approach that may help the body maintain healthier energy balance during cancer-related challenges.

    Related Content

    View Paper

    Inhibition of Cancer Cell Metastasis and Invasion

    Study Title: (−)-Epicatechin Inhibits Metastatic-Associated Proliferation, Migration, and Invasion of Murine Breast Cancer Cells In Vitro

    Citation: Pérez-Durán et al., 2023 · Molecules

    What the Study Found: (−)-Epicatechin significantly inhibited proliferation, migration, and invasion of murine breast cancer cells in vitro. It reduced key metastatic markers and altered cell motility pathways. The effects were dose-dependent and linked to modulation of mitochondrial and redox signaling.

    What this means in real life: Metastatic cancer cells depend on dysregulated mitochondrial metabolism to fuel rapid movement and survival. This study shows that (−)-epicatechin can suppress those aggressive behaviors by interfering with energy and redox pathways inside the cells. Supporting mitochondrial health may help create an internal environment less favorable to cancer progression.

    Related Content

    View Paper

    Synergistic Cytotoxicity with Cisplatin in Lung Cancer Cells

    Study Title: Characterization Of The Cytotoxic Effects Of The Combination Of Cisplatin And Flavanol (-)-Epicatechin On Human Lung Cancer Cell Line A549. An Isobolographic Approach

    Citation: Varela-Castillo et al., 2018 · Experimental Oncology

    What the Study Found: The combination of cisplatin and (−)-epicatechin showed synergistic cytotoxic effects on human lung cancer A549 cells. Isobolographic analysis confirmed greater-than-additive cell death compared with either compound alone. The flavanol enhanced cisplatin’s anticancer activity without increasing toxicity to non-cancer cells in the model.

    What this means in real life: Cancer cells often rely on altered mitochondrial metabolism to survive and resist chemotherapy. This study demonstrates that (−)-epicatechin can amplify cisplatin’s ability to disrupt energy production and trigger cell death in lung cancer cells. Mitochondrial support may therefore play a complementary role in helping conventional therapies work more effectively while protecting healthy cellular energy balance.

    Related Content

    View Paper

    Renal Protection via Mitochondrial Integrity in Chemotherapy Injury

    Study Title: Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy

    Citation: Tanabe et al., 2012 · American Journal of Physiology, Renal Physiology

    What the Study Found: In a cisplatin-induced nephropathy model, (−)-epicatechin significantly reduced kidney damage markers and preserved mitochondrial function. It limited oxidative stress, maintained mitochondrial membrane potential, and decreased cell death in renal tissue. The protective effects were directly linked to mitochondrial stabilization.

    What this means in real life: The kidneys are highly dependent on mitochondrial energy to filter blood and handle toxins; chemotherapy like cisplatin can rapidly damage these mitochondria, leading to acute kidney injury. This study shows that (−)-epicatechin protects renal mitochondria, preserving their structure and function under toxic stress. At Mitozz we focus on mitochondrial health because supporting cellular energy capacity helps vital organs like the kidneys stay resilient during metabolic or chemical challenges.

    Related Content

    View Paper

    Epicatechin and Breast Cancer Cell Migration in Vitro

    Study Title: (−)-Epicatechin inhibits metastatic-associated proliferation, migration, and invasion of murine breast cancer cells in vitro

    Citation: Pérez-Durán et al., 2023 · Molecules

    What the Study Found: This in vitro study evaluated the effects of (-)-epicatechin on murine breast cancer cells, focusing on behaviors associated with metastatic potential. The researchers reported that (-)-epicatechin reduced cell proliferation and decreased migration and invasion in experimental assays. The paper also examined molecular signals related to epithelial-mesenchymal transition and matrix remodeling, including changes in markers such as vimentin, E-cadherin, and MMP-9. These findings suggest that (-)-epicatechin influenced several cell behaviors and signaling markers linked to cancer-cell movement in this laboratory model.

    What this means in real life: This study is useful because it looks beyond general antioxidant language and examines specific cancer-cell behaviors in a controlled laboratory setting. The results suggest that (-)-epicatechin may affect pathways related to proliferation, migration, invasion, and cell phenotype in murine breast cancer cells. This does not mean (-)-epicatechin treats, prevents, or slows breast cancer in humans. The findings are preclinical and should be understood as early mechanistic evidence that requires much more research before any clinical conclusions can be made.

    Clinical Relevance: In vitro murine breast cancer cell study, focused on proliferation, migration, invasion, epithelial-mesenchymal transition markers, and metastatic-associated behavior.

    Related Content:

    View Paper

    Epicatechin and Triple-Negative Breast Cancer Tumor Growth in Mice

    Study Title: Anticancer potential of (−)-epicatechin in a triple-negative mammary gland model

    Citation: Almaguer et al., 2021 · Journal of Pharmacy and Pharmacology

    What the Study Found: This study evaluated (-)-epicatechin in a mouse model of triple-negative mammary gland cancer using 4T1 breast cancer cells in female BALB/c mice. The researchers reported that (-)-epicatechin reduced tumor growth, with 2 and 3 mg/kg/day doses showing effects comparable to doxorubicin in this model. The study also found improved survival in (-)-epicatechin-treated animals compared with controls. Mechanistically, the authors reported changes in AMPK phosphorylation, Akt phosphorylation, and mTOR expression, suggesting that (-)-epicatechin may influence pathways involved in tumor-cell proliferation.

    What this means in real life: This paper is relevant because it examines (-)-epicatechin in an animal model of an aggressive breast cancer subtype, while also looking at signaling pathways tied to cell growth and metabolism. The results are preclinical and should not be interpreted as evidence that (-)-epicatechin treats, prevents, or slows breast cancer in humans. The practical takeaway is narrower: this study adds to early mechanistic research on how (-)-epicatechin may affect tumor biology in controlled experimental models.

    Clinical Relevance: Mouse triple-negative mammary gland cancer model, tumor growth and survival endpoints, AMPK and Akt/mTOR signaling; not human clinical evidence.

    Related Content:

    View Paper

    Continue Exploring Mitochondrial Science

    Mitochondria 101  |  Visit Our Blog  |  Join the Community